Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Alatas, C. Naz, G. Ak, H. Yildirim, M. Metintas, S. Erginel (Eskisehir, Turkey). The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia. Eur Respir J 2007; 30: Suppl. 51, 2924

Member's Comments

No comment yet.

Related content which might interest you: Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 D-dimer is an independent marker predicting severity in community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Quality-indicators and prognostics in CAP in three populations Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 The role of procoagulant activity in patients with community acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Virusologic research in healthy persons of closed collectives Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Predictive value of plasma D-dimer in patients with community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007